Benzinga

Benzinga

Benzinga

jueves, agosto 20

Tenax Therapeutics Inc

TENXNASDAQ
Trade with Public
Trade with Public
$1.90
0.2011.76%
al cierre: Aug 18, 5:00 PM EST
$1.89
0.1911.18%
Premercado: 7:01 AM EST
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Tenax Therapeutics Financials

Tenax Therapeutics (TENX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Tenax Therapeutics Q2 EPS $(0.35) Beats $(0.37) Estimate

Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.37) by 5.41 percent. This is a 29.63 percent decrease over losses of $(0.27) per share
Benzinga Newsdesk

Earnings Scheduled For May 12, 2026

Benzinga Insights

PRO
Tenax Therapeutics Q1 EPS $(0.35) Beats $(0.58) Estimate

Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.58) by 39.66 percent. This is a 25 percent decrease over losses of $(0.28) per share from
Benzinga Newsdesk

PRO
Tenax Therapeutics Q4 EPS $(0.38) Beats $(0.41) Estimate

Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.41) by 7.32 percent. This is a 111.11 percent decrease over losses of $(0.18) per share
Benzinga Newsdesk

PRO
Tenax Therapeutics Q3 EPS $(0.40) Misses $(0.32) Estimate

Benzinga Newsdesk

PRO
Tenax Therapeutics Q2 EPS $(0.27) Misses $(0.24) Estimate

Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved